Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American Oriental Bioengineering Gets NYSE Non-compliance Notice

American Oriental Bioengineering, Inc. (AOB: Quote) on Friday said the New York Stock Exchange has notified the company that it is not in compliance with NYSE rules due to the company's failure to timely file its Annual Report on Form 10-K with the Securities and Exchange Commission.

The company had said earlier that the annual audit of its financial statements for 2011 showed some inconsistencies and the audit committee has commenced an independent investigation into those matters.

Under NYSE rules, when a company does not comply with annual report filing requirements, the exchange allows a company an additional six months to file its annual report in order to regain compliance. In the case of the company, the annual report would be due on or before October 29.

Click here to receive FREE breaking news email alerts for American Oriental Bioengineering Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.